Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nuclear receptor coactivator 2 [740-753] () | BDBM197677 (US9216981, 5 | US9550781, 1) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205040 (US9550781, 27 | n-(3-(2-(9h-purin-6-yl)phenylamino...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM197689 (US9216981, 17 | US9550781, 24) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM197706 (US9216981, 35 | US9550781, 15) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM50165873 (CHEMBL3800014 | US9550781, 19) | UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205021 (US9550781, 18 | n-(3-(3-(9h-purin-6-yl)pyridin-2-y...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205007 (US9550781, 4 | n-(3-(3-(9h-purin-6-yl)pyridin-2-yl...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205013 (US9550781, 10 | n-(3-(3-(9h-purin-6-yl)pyridin-2-y...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205012 (US9550781, 9 | n-(3-(3-(9h-purin-6-yl)pyridin-2-yl...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205011 (US9550781, 8 | n-(3-(3-(9h-purin-6-yl)pyridin-2-yl...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205010 (US9550781, 7 | n-(3-(3-(9h-purin-6-yl)pyridin-2-yl...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205009 (US9550781, 6 | n-(3-(3-(9h-purin-6-yl)pyridin-2-yl...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205008 (US9550781, 5 | n-(3-(3-(9h-purin-6-yl)pyridin-2-yl...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM50030474 (Avandamet | Avandaryl | Avandia | BRL-49653 | CHEB...) | UniProtKB/SwissProt GoogleScholar AffyNet | Purchase DrugBank MCE PC cid PC sid PDB UniChem Similars | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205005 (US9550781, 3 | n-(2,4-difluoro-3-(3-(8-methyl-9h-p...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205038 (US9550781, 26 | n-(3-(3-(7h-pyrrolo[2,3-d]pyrimidi...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205035 (US9550781, 25 | n-(3-(3-(1h-pyrazolo[3,4-d]pyrimid...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205024 (US9550781, 21 | n-(3-(3-(9h-purin-6-yl)pyridin-2-y...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205023 (US9550781, 20 | n-(3-(3-(9h-purin-6-yl)pyridin-2-y...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205020 (US9550781, 17 | n-(3-(3-(9h-purin-6-yl)pyridin-2-y...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205017 (US9550781, 14 | n-(3-(3-(9h-purin-6-yl)pyridin-2-y...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM50165871 (CHEMBL3798635 | US9550781, 13) | UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205014 (US9550781, 11 | n-(3-(3-(9h-purin-6-yl)pyridin-2-y...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM50165865 (CHEMBL3798423 | US9550781, 23) | UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205025 (US9550781, 22 | n-(3-(3-(9h-purin-6-yl)pyridin-2-y...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205042 (US9550781, 28 | n-(3-(2-(9h-purin-6-yl)phenylamino...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM205015 (US9550781, 12 | n-(3-(3-(9h-purin-6-yl)pyridin-2-y...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. US Patent | Assay Description In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was... | US Patent US9550781 (2017) BindingDB Entry DOI: 10.7270/Q2X63PXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228151 ((2s)-2-ethoxy-3-{4-[2-(3-methoxyphenyl)-2-oxoethox...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228140 ((2s)-2-ethoxy-n-methoxy-3-{4-[(4-methoxypyridin-2-...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228150 (US9562012, 20 | ethyl (2s)-2-ethoxy-3-{4-[2-(3-met...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.09E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228137 ((2s)-2-ethoxy-3-{4-[(4-methoxypyridin-2-yl)methoxy...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.18E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228129 (US9562012, mitoglitazone) | UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | US Patent | n/a | n/a | 2.66E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228134 (US9562012, 4 | ethyl (2s)-2-ethoxy-3-[4-(pyridin-2...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.77E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228147 (US9562012, 17 | ethyl (2r)-2-ethoxy-3-{4-[(2s)-2-h...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.77E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228141 ((2s)-2-ethoxy-n-hydroxy-3-{4-[(4-methoxypyridin-2-...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228131 (US9562012, 1 | ethyl (2s)-2-ethoxy-3-(4-hydroxyphe...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.89E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228143 ((2r)-2-ethoxy-3-{4-[2-(3-methoxyphenyl)-2-oxoethox...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.14E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228138 ((2s)-2-ethoxy-n-hydroxy-3-{4-[(4-methoxypyridin-2-...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.85E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228132 (US9562012, 2 | ethyl (2r)-2-ethoxy-3-(4-hydroxyphe...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228142 (US9562012, 12 | ethyl (2r)-2-ethoxy-3-{4-[2-(3-met...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.64E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228146 ((2r)-2-ethoxy-3-{4-[(2s)-2-hydroxy-2-(3-methoxyphe...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.91E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228136 (US9562012, 6 | ethyl (2s)-2-ethoxy-3-{4-[(4-methox...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.95E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228145 ((2r)-2-ethoxy-n-methoxy-3-{4-[2-(3-methoxyphenyl)-...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228148 ((2r)-2-ethoxy-n-hydroxy-3-{4-[(2s)-2-hydroxy-2-(3-...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228133 ((2s)-2-ethoxy-n-hydroxy-3-{4-[(3-iodobenzyl)oxy]ph...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228144 ((2r)-2-ethoxy-n-methoxy-3-{4-[2-(3-methoxyphenyl)-...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228135 ((2s)-2-ethoxy-n-hydroxy-3-[4-(pyridin-2-ylmethoxy)...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228149 ((2r)-2-ethoxy-3-{4-[(2r)-2-hydroxy-2-(3-methoxyphe...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 [740-753] () | BDBM228139 ((2s)-2-ethoxy-n-methoxy-3-{4-[(4-methoxypyridin-2-...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Metabolic Solutions Development Company, LLC US Patent | Assay Description PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I... | US Patent US9562012 (2017) BindingDB Entry DOI: 10.7270/Q26H4KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor coactivator 2 (Homo sapiens (Human)) | BDBM42885 (2-(7-Ethyl-[1,3]dioxolo[4,5-g]quinolin-6-ylsulfany...) | PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | PCBioAssay | n/a | n/a | n/a | n/a | >7.94E+4 | n/a | n/a | n/a | n/a |
The Scripps Research Institute Molecular Screening Center Curated by PubChem BioAssay | Assay Description Source (MLSCN Center Name): The Scripps Research Institute Molecular Screening Center Center Affiliation: The Scripps Research Institute (TSRI) Assay... | PubChem Bioassay (2008) BindingDB Entry DOI: 10.7270/Q2QZ28CS | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 398 total ) | Next | Last >> |